The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study-Reference-Cited by-同舟云学术

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study

Published:2003-06 Issue:6 Volume:48 Page:1513-1520
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Kalden J. R.,Schattenkirchner M.,Sörensen H.,Emery P.,Deighton C.,Rozman B.,Breedveld F.

Funder

Aventis Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference21 articles.

1. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies;Fries;Arthritis Rheum,1996

2. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone;Pincus;J Rheumatol,1992

3. Adverse drug reactions of DMARDs and DC-ARTs in rheumatoid arthritis;Wolfe;Clin Exp Rheumatol,1997

4. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase;Davis;Biochemistry,1996

5. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans: disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors;Fairbanks;J Biol Chem,1995

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dexamethasone Palmitate Encapsulated in Palmitic Acid Modified Human Serum Albumin Nanoparticles for the Treatment of Rheumatoid Arthritis;Journal of Pharmaceutical Sciences;2024-09

2. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry;Rheumatology;2024-01-18

3. The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis;Frontiers in Immunology;2023-09-07

4. Rheumatoid arthritis: Pathophysiology, current therapeutic strategies and recent advances in targeted drug delivery system;Materials Today Communications;2023-06

5. An update on novel therapeutic intervention in Rheumatoid arthritis;International Immunopharmacology;2022-08